OPUS GENETICS INC (IRD) Stock Earnings & Estimates
NASDAQ:IRD - US67577R1023 - Common Stock
1.33 USD
-0.03 (-2.21%)
1.29 USD
-0.04 (-3.01%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 39.85M 6,654.24% | 19.049M -52.20% | 10.992M -42.30% | 14.803M 34.67% | 28.064M 89.58% | 20.252M -27.84% | 25.71M 26.95% | 38.672M 50.42% | 69.785M 80.45% | 105.69M 51.45% | 139.51M 32.00% | |
| EBITDA YoY % growth | 18.23M 180.31% | -8.557M -146.94% | -31.364M -266.53% | 8.787M 128.02% | 20.907M 137.93% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 18.23M 180.31% | -8.563M -146.97% | -31.374M -266.39% | -36.545M -16.48% | -32.87M 10.06% | -42.153M -28.24% | -40.856M 3.08% | -35.739M 12.52% | -5.595M 84.34% | 44.765M 900.03% | 69.287M 54.78% | |
| Operating Margin | 45.75% | -44.95% | -285.43% | -246.88% | -117.13% | -208.14% | -158.91% | -92.42% | -8.02% | 42.36% | 49.66% | |
| EPS YoY % growth | 0.76 147.80% | -0.48 -163.16% | -1.10 -129.17% | -0.66 40.01% | -0.41 38.39% | -0.51 -24.22% | -0.22 56.00% | 0.00 100.00% | 0.39 | 0.77 94.87% | 1.04 35.53% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 53.85% | -0.13 41.47% | -0.17 28.46% | -0.15 -26.25% | -0.04 69.81% | -0.04 68.63% | -0.17 | -0.17 -13.33% | -0.18 -350.00% | -0.18 -350.00% |
| Revenue Q2Q % growth | 3.415M -11.69% | 4.064M -5.53% | 2.525M -42.22% | 2.525M -12.39% | 12.625M 269.69% | 12.625M 210.65% | 2.525M | 2.525M | 2.525M -80.00% | 2.525M -80.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.883M -18.30% | -8.656M 8.20% | -12.373M -35.53% | -12.878M -53.19% | -3.283M 63.05% | -3.788M 56.24% | -14.393M -16.33% | -14.898M -15.69% | -15.403M -369.23% | -15.908M -320.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.12 60.00% | -0.21 | 0.09 | 42.04% |
| Q1 2025 Q2Q % growth | -0.24 17.24% | -0.25 | 0.01 | 4.95% |
| Q4 2024 Q2Q % growth | -0.22 -4.76% | -0.26 | 0.04 | 15.14% |
| Q3 2024 Q2Q % growth | -0.29 -216.00% | -0.24 | -0.05 | -20.90% |
| Q2 2024 Q2Q % growth | -0.30 -25.00% | -0.26 | -0.04 | -16.48% |
| Q1 2024 Q2Q % growth | -0.29 -3.57% | -0.14 | -0.15 | -114.28% |
| Q4 2023 Q2Q % growth | -0.21 -113.29% | -0.05 | -0.16 | -296.04% |
| Q3 2023 Q2Q % growth | 0.25 213.64% | -0.22 | 0.47 | 211.50% |
| Q2 2023 Q2Q % growth | -0.24 4.00% | -0.23 | -0.01 | -5.14% |
| Q1 2023 Q2Q % growth | -0.28 20.00% | -0.16 | -0.12 | -80.02% |
| Q4 2022 Q2Q % growth | 1.58 551.43% | 0.98 | 0.60 | 61.69% |
| Q3 2022 Q2Q % growth | -0.22 12.00% | -0.29 | 0.07 | 24.45% |
| Q2 2022 Q2Q % growth | -0.25 51.92% | -0.34 | 0.09 | 25.44% |
| Q1 2022 Q2Q % growth | -0.35 25.53% | -0.35 | 0.00 | 0.99% |
| Q4 2021 Q2Q % growth | -0.35 93.24% | -0.29 | -0.06 | -20.88% |
| Q3 2021 Q2Q % growth | -0.25 | -0.36 | 0.11 | 30.86% |
| Q2 2021 Q2Q % growth | -0.52 | -0.37 | -0.15 | -41.70% |
| Q1 2021 Q2Q % growth | -0.47 | -0.72 | 0.25 | 34.69% |
| Q4 2020 Q2Q % growth | -5.18 | -0.42 | -4.76 | -1,121.12% |
| Q3 2019 Q2Q % growth | -1.96 | -2.18 | 0.22 | 10.16% |
| Q2 2019 Q2Q % growth | -2.44 | -3.45 | 1.01 | 29.22% |
| Q1 2019 Q2Q % growth | -2.48 | -3.77 | 1.29 | 34.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.882M 159.17% | 4.085M | -1.203M | -29.45% |
| Q1 2025 Q2Q % growth | 4.37M 155.41% | 3.13M | 1.24M | 39.62% |
| Q4 2024 Q2Q % growth | 4.302M 154.41% | 3.023M | 1.279M | 42.31% |
| Q3 2024 Q2Q % growth | 3.867M -67.61% | 2.311M | 1.556M | 67.33% |
| Q2 2024 Q2Q % growth | 1.112M -69.70% | 2.485M | -1.373M | -55.25% |
| Q1 2024 Q2Q % growth | 1.711M -2.23% | 4.295M | -2.584M | -60.16% |
| Q4 2023 Q2Q % growth | 1.691M -95.76% | 5.403M | -3.712M | -68.70% |
| Q3 2023 Q2Q % growth | 11.94M | 3.055M | 8.885M | 290.83% |
| Q2 2023 Q2Q % growth | 3.67M | 2.449M | 1.221M | 49.86% |
| Q1 2023 Q2Q % growth | 1.75M | 2.981M | -1.231M | -41.29% |
| Q4 2022 Q2Q % growth | 39.85M | 29.74M | 10.11M | 33.99% |
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | 100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 36.9% | 47% | 22.84% | 27.41% |
| Revenue | -18.24% | -15.47% | -13.45% | -11.06% |